© 2020 MJH Life Sciences and OncLive. All rights reserved.
May 19, 2020
Manuel Hidalgo Medina, MD, PhD, discusses some of the exciting pancreatic cancer research presented at the 2020 ACCR Virtual Annual Meeting I.
May 02, 2020
Manuel Hidalgo Medina, MD, PhD, chief, Division of Hematology and Medical Oncology, Weill Cornell Medicine/NewYork-Presbyterian Hospital, discusses that rationale for using patient-derived organoids (PDOs) in pancreatic cancer.
December 17, 2019
Manuel Hidalgo Medina, MD, PhD, discusses microsatellite instability and germline testing patients with pancreatic cancer.
December 05, 2019
Manuel Hidalgo Medina, MD, PhD, discusses treatment considerations in pancreatic cancer.